FAQ
Frequently asked questions
Answers to the questions research sites, CROs and sponsors ask before they sign: what Bond Health reads in the chart, how the voice and text agents treat patients, what the IRB reviews, how PHI is handled and how pricing works. Most answers link to the page with more detail, and figures Bond publishes about itself are labeled as Bond's.
What does this FAQ cover?
The first seven questions are the ones on the Bond Health homepage. The rest follow in this order: product, data and integrations, IRB and consent, patients' rights and AI disclosure, pricing and contracts, implementation and support, and security.
Each stage has its own page (Identify, Engage and Consent), and so do integrations, pricing, implementation and security.
Where do I start if I run a site?
Before screening starts, three things need sign-off: the business associate agreement and your security review, your IRB's review of the outreach scripts, and your IT team's approval of the EHR connection. Full EHR integration takes 48 hours.[1]
For the timeline, read implementation. For the IRB packet, start from IRB submission language for AI outreach. For what changes day to day, see Bond for research sites.
Where do I start if I work at a CRO or sponsor?
Start with reporting and pricing. Bond reports patients matched, contacted, pre-screened, consented and randomized, plus time to enrollment and screen-failure signals, in real-time dashboards and regular reports for sites, CROs and sponsors. The success fee is paid per randomized patient, so cost follows enrollment.[1] See Bond for sponsors, Bond for CROs and pricing.
What if my question is not answered here?
Email [email protected] or book a demo.
Bring one protocol. The call can cover your EHR, your IRB's process and the criteria that are hardest to screen.
Frequently asked questions
How does Bond Health connect to EHR data?
How does Bond Health validate trial eligibility logic?
How do Bond Health's voice and SMS/text agents handle PHI?
What is Bond Health's implementation timeline?
What is Bond Health's security posture?
What outcomes does Bond Health measure for research sites?
Can Bond Health run Meta and Google ads for our studies?
What does Bond do?
What parts of the chart does Bond read?
How accurate is Bond's eligibility screening?
What results has Bond published?
Does Bond replace study coordinators?
How does Bond guard against bias in who gets contacted?
How do the voice and text agents work?
Does Bond obtain informed consent from patients?
Which EHRs does Bond work with?
Does Bond integrate with CRIO and other CTMS systems?
Who at our site can see patient data in Bond?
Do language model providers see patient data?
What happens to our data when the contract ends?
Do we need IRB approval to use Bond?
What allows Bond to screen records before a patient has agreed to anything?
Do patients know they are talking to an AI?
How does a patient stop calls or texts?
Do TCPA rules apply to AI voice calls?
How is Bond priced?
What is included in every engagement?
Can a site start without EHR integration?
What does our site need to provide during implementation?
Is Bond SOC 2 compliant?
Is Bond cleared by the FDA?
Sources
- 1.Bond Health: platform overview, FAQ and pricing · Bond Health, 2026
- 2.Bond Health product information · Bond Health, 2026Capabilities, pricing and compliance status described by Bond Health, September 2026.
- 3.Terminology Infrastructure and Graph-Grounded RAG for Clinical Trial Patient Matching · Bond Health, preprint, 2026Goel R. Bond Health preprint, August 2026. No public URL yet.
- 4.Achieving a Major Milestone: Health IT Developers Certify to Cures Update · HealthIT.gov (ASTP/ONC), 2023Quote: "More than 95 percent of Certified Health IT developers met the compliance deadline to update and provide their customers with new technology."
- 5.Sociodemographic bias in large language model clinical trial screening · Journal of the American Medical Informatics Association, 2026Quote: "Across 58 protocols and 5.3 million evaluations, eligibility judgments were largely stable across identities. [...] Homelessness produced the largest negative eligibility shift [...] disparities emerged in domains requiring inference about behavior or resources." Physician-validated vignettes in 33 identity variants, assessed by nine language models. JAMIA 2026;33(8):1504-1509.
- 6.21 CFR 56.111 Criteria for IRB approval of research · eCFR, Office of the Federal Register, 2026Paragraph (a)(3): selection of subjects is equitable. Text current as of September 1, 2026.
- 7.ICH Harmonised Guideline: Guideline for Good Clinical Practice E6(R3) · International Council for Harmonisation, 2025Final version adopted January 6, 2025. Sections 2.4.2 (IRB approval of recruitment procedures) and 2.8.5 (who conducts the consent process).
- 8.Recruiting Study Subjects: Guidance for Institutional Review Boards and Clinical Investigators · U.S. Food and Drug Administration, 1998Information sheet, January 1998; content current as of 2018. Quotes: "FDA considers direct advertising for study subjects to be the start of the informed consent and subject selection process." and, on the receptionist script used at first contact, "The IRB should assure the procedures followed adequately protect the rights and welfare of the prospective subjects."
- 9.45 CFR 164.512(i) Uses and disclosures for research purposes · eCFR, Office of the Federal Register, 2026Text current as of September 1, 2026.
- 10.45 CFR 46.116 General requirements for informed consent · eCFR, Office of the Federal Register, 2026Paragraph (g), screening, recruiting, or determining eligibility. Text current as of September 1, 2026.
- 11.45 CFR 160.103 Definitions (business associate) · eCFR, Office of the Federal Register, 2026Quote: "(iii) A subcontractor that creates, receives, maintains, or transmits protected health information on behalf of the business associate." Text retrieved from the eCFR API, current as of September 1, 2026.
- 12.45 CFR 164.504(e) Business associate contracts · eCFR, Office of the Federal Register, 2026Paragraph (e)(2)(ii)(D): "ensure that any subcontractors that create, receive, maintain, or transmit protected health information on behalf of the business associate agree to the same restrictions and conditions that apply to the business associate with respect to such information". Paragraph (e)(2)(ii)(J): "At termination of the contract, if feasible, return or destroy all protected health information received from, or created or received by the business associate on behalf of, the covered entity that the business associate still maintains in any form and retain no copies of such information or, if such return or destruction is not feasible, extend the protections of the contract to the information" Text retrieved from the eCFR API, current as of September 1, 2026.
- 13.AB-3030 Health care services: artificial intelligence (Chapter 848, Statutes of 2024) · California Legislative Information, 2024Health and Safety Code 1339.75. Operative January 1, 2025.
- 14.H.B. No. 149, Texas Responsible Artificial Intelligence Governance Act (enrolled) · Texas Legislature Online, 2025Business and Commerce Code Sec. 552.051. Effective January 1, 2026.
- 15.Declaratory Ruling, Implications of Artificial Intelligence Technologies on Protecting Consumers from Unwanted Robocalls and Robotexts (FCC 24-17) · Federal Communications Commission, 2024Adopted February 2, 2024; released February 8, 2024.
- 16.Report and Order, Rules and Regulations Implementing the Telephone Consumer Protection Act of 1991 (FCC 24-24) · Federal Communications Commission, 2024Revocation rules codified at 47 CFR 64.1200(a)(10); effective April 11, 2025.
Related pages
Pricing
The volume-based platform fee and the success fee per randomized patient.
ReadSecurity
BAAs, encryption, access control, audit logging and the Trust Center.
ReadImplementation
What happens between signing and live screening, step by step.
ReadIntegrations
How Bond connects to EHRs, CTMS systems and calendars.
ReadIRB and HIPAA rules for patient outreach
Authorizations, waivers and what the IRB reviews.
Read